Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Armata Pharmaceuticals, Inc.

Clinical trials sponsored by Armata Pharmaceuticals, Inc., explained in plain language.

Completed 2
Sort by
  • New drug shows promise against staph blood infections

    Disease control Completed

    This study tested a new medicine called AP-SA02, given through a vein, along with standard antibiotics for adults with a Staph blood infection. The main goal was to check if the combination is safe and tolerable. Researchers also looked at whether it helped clear the infection fa…

    Phase: PHASE1, PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 12:00 UTC

  • Virus cocktail inhaled to fight Drug-Resistant lung infection

    Disease control Completed

    This study tested an inhaled mixture of bacteria-killing viruses (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. Participants received either the phage therapy or a placebo by inhalation. The goal was to see if the phages could safely reduce the…

    Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 08:08 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space